Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dietary Fiber and Probiotics in Schizophrenia or Bipolar Disorder
NCT03379597Completed
- Sponsor
- Central South University
- Start
- Nov 2017
- Primary completion
- May 2021
- Modality
- Yeast Strains, Defined Consortia, Bacterial Strains
- Countries
- 1
01
Overview
Randomised, open-label trial of bifidobacterium longum/lactobacillus acidophilus/enterococcus faecalis in schizophrenia and bipolar disorder (BD) (4 arms), sponsored by Central South University. Primary endpoints: MATRICS Consensus Cognitive Battery composite score at 12 weeks and Body Mass Index at 12 weeks. Started Nov 2017; status: completed.
02
Drugs
bifidobacterium longum/lactobacillus acidophilus/enterococcus faecalis
03
Conditions
schizophreniabipolar disorder (BD)
Beyond the preview
Go deeper on NCT03379597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03379597.